0001104659-19-053357.txt : 20191008
0001104659-19-053357.hdr.sgml : 20191008
20191008142425
ACCESSION NUMBER: 0001104659-19-053357
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190930
FILED AS OF DATE: 20191008
DATE AS OF CHANGE: 20191008
EFFECTIVENESS DATE: 20191008
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 191142517
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
09-30-2019
09-30-2019
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Managing Director, Versant Venture Management, LLC
(415) 801-8100
/s/ Robin L. Praeger
San Francisco
CA
10-07-2019
0
8
258454718
false
INFORMATION TABLE
2
a19-19736_1informationtable.xml
INFORMATION TABLE
Clovis Oncology, Inc.
Common Stock
189464100
400290
101855
SH
OTR
0
101855
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
2784014
543753
SH
OTR
0
543753
0
Gritstone Oncology, Inc.
Common Stock
39868T105
26793792
3102929
SH
OTR
0
3102929
0
Second Sight Medical Products, Inc.
Common Stock
81362J100
3706255
4492975
SH
OTR
0
4492975
0
Ocular Therapeutix, Inc.
Common Stock
67576A100
6734767
2215384
SH
OTR
0
2215384
0
Audentes Therapeutics, Inc.
Common Stock
05070R104
15559500
553916
SH
OTR
0
553916
0
CRISPR Therapeutics AG
Common Stock
H17182108
173546331
4233870
SH
OTR
0
4233870
0
Veracyte, Inc.
Common Stock
92337F107
28929768
1205407
SH
OTR
0
1205407
0